logo

For the Inventor, By the Inventor

Kapellen, Belgium

Walter Boudewijn Leopold Wouters

USPTO Granted Patents = 19 


Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 73(Granted Patents)


Location History:

  • Beerse, BE (2015)
  • Kapellen, BE (2001 - 2018)

Company Filing History:

goldMedal17 out of 2,077 
 
Janssen Pharmaceutica Nv
 patents
silverMedal1 out of 32 
 
Janssen Pharmaceutica
 patents
bronzeMedal1 out of 832,718 
Other
 patents

Years Active: 2001-2018

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 10150757 - Quinazolinone derivatives as PARP inhibitors (2018-12-11),
2. 9522905 - Quinazolinone derivatives as PARP inhibitors (2016-12-20),
3. 9255080 - Quinazolinedione derivatives as PARP inhibitors (2016-02-09),
4. 9115084 - 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2015-08-25),
5. 8623884 - Quinazolinedione derivatives as PARP inhibitors (2014-01-07),
6. 8623872 - Quinazolinone derivatives as PARP inhibitors (2014-01-07),
7. 8524714 - 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2013-09-03),
8. 8450486 - 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2013-05-28),
9. 8188103 - Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors (2012-05-29),
10. 8080557 - Quinazolinedione derivatives as PARP inhibitors (2011-12-20),
11. 8071612 - 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2011-12-06),
12. 7928104 - 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2011-04-19),
13. 7879857 - 6-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors (2011-02-01),
14. 7855207 - 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors (2010-12-21),
15. 7803795 - Phthalazine derivatives as parp inhibitors (2010-09-28),

Title: Innovator Spotlight: Walter Boudewijn Leopold Wouters

Introduction: Walter Boudewijn Leopold Wouters, based in Kapellen, Belgium, is a notable inventor with a remarkable portfolio of 19 patents. His contributions, particularly in the field of pharmaceuticals, showcase his dedication to advancing medical science through innovation.

Latest Patents: Among his most recent inventions are the quinazolinone derivatives identified as PARP inhibitors. These compounds, represented by the formula (I), demonstrate a promising potential as therapeutic agents. The patents detail their specific chemical structures and their pharmaceutical applications, indicating a significant leap forward in the treatment of various diseases.

Career Highlights: Wouters’ career includes notable tenures at Janssen Pharmaceutica NV, where he honed his expertise in drug development and innovative pharmaceutical solutions. His work has notably impacted the industry, leading to advancements that benefit both medical professionals and patients alike.

Collaborations: Throughout his career, Wouters has collaborated with esteemed colleagues such as Jacobus Alphonsus Josephus van Dun and Maria Victorina Francisca Somers. These collaborations have further enriched his work and have contributed to his success in the patenting process.

Conclusion: Walter Boudewijn Leopold Wouters stands out as a prominent figure in the world of invention, with a strong focus on pharmaceutical advancements. His work not only reflects individual brilliance but also underscores the importance of collaboration and innovation in achieving significant breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…